Abstract
Current imaging modalities are accurate in establishing the diagnosis and extent of thoracic Hodgkin disease. After treatment, however, it is extremely difficult to differentiate potential residual active neoplastic disease from scar tissue, or identify early recurrence. We evaluated the contribution of MRI in the assessment of the response to treatment of thoracic Hodgkin disease in the assumption that scar formation would be characterized by low signal intensity in all pulse sequences, whereas active tumor should maintain a degree of high signal intensity on T2-weighted images. In 47 occasions (23 patients) both CT and MRI were able to identify correctly active disease, but had low specificity in confirming remission because of residual tissues masses. High signal intensity on T2-weighted MR images often persisted despite remission, probably because of edema, necrosis, granulation or other factors. MRI was somewhat more specific than CT and may be quite valuable to confirm remission in patients with residual masses that no longer appear hyperintense on T2 after treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Lanzkowsky P (1989) Manual of pediatric hematology and oncology. Churchill Livingstone, New York, pp 251–269
Lewis E, Bernardino ME, Salvador PG, Cabanillas FF, Barnes PA, Thomas JL (1982) Post therapy CT-detected mass in lymphoma patients: is it viable tissue? J Comput Assist Tomogr 6: 792–795
Stolar CJH, Garvin JH, Rustad DG, Amodio JB, Lipton JM (1987) Residual or recurrent chest mass in pediatric Hodgkin's disease: a surgical problem? J Pediatr Hematol Oncol 9: 289–294
Jochelson M, Marich P, Balikian J, Rosenthal D, Cannelos G (1985) The significance of the residual mediastinal mass in treated Hodgkin's disease. J Clin Oncol 3: 637–640
Drossman SR, Schiff RG, Kronfeld GD, McNamara J, Leonidas JC (1990) Lymphoma of the mediastinum and neck: evaluation with Ga-67 imaging and CT correlations. Radiology 174: 171–175
Ebner F, Kressel HY, Mintz MC et al. (1988) Tumor recurrence versus fibrosis in the female pelvis: differentiation with MR imaging at 1.5 T. Radiology 166: 333–340
Nyman R, Rehn S, Ericsson A et al. (1987) An attempt to characterize malignant lymphoma in spleen liver and lymph nodes with magnetic resonance imaging. Acta Radiol 28: 527–533
Nyman N, Rehn S, Glimelius B, Hagberg H, Hemmingsson A, Jung B (1987) Magnetic resonance imaging for assessment of treatment effects in mediastinal Hodgkin disease. Acta Radiol 28: 145–151
Nyman RS, Rehn SM, Glimelius BLG, Hagberg HE, Hemmingsson AL, Sundstrom CJ (1989) Residual mediastinal masses in Hodgkin disease: prediction of size with MR imaging. Radiology 170: 435–440
Negendank WG, Al-Katib AM, Karanes C, Smith MR (1990) Lymphomas: MR imaging contrast characteristics with clinical-pathologic correlations. Radiology 177: 290–316
Lee JKT, Glazer HS (1990) Controversy in the MR imaging appearance of fibrosis. Radiology 177: 21–22
Webb WR (1989) MR imaging of treated mediastinal Hodgkin disease. Radiology 170: 315–316
Author information
Authors and Affiliations
Additional information
Presented to the 35th Annual Meeting of the Society for Pediatric Radiology, Orlando, Florida, May 1992
Rights and permissions
About this article
Cite this article
Elkowitz, S.S., Leonidas, J.C., Lopez, M. et al. Comparison of CT and MRI in the evaluation of therapeutic response in thoracic Hodgkin disease. Pediatr Radiol 23, 301–304 (1993). https://doi.org/10.1007/BF02010921
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02010921